Treatment of Helicobacter pylori infection: Where are we now?

Abstract excerpt

Gastric cancer and Helicobacter pylori infection remain a burden in many Asian countries. In the face of rising antibiotic resistance, the eradication rate of standard triple therapy is declining in many Asian countries. We reviewed the updated epidemiology of gastric cancer, prevalence of H. pylori infection, and antibiotic resistance in Asia. We also reviewed the strategies to improve the efficacy of H. pylori...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Probiotics
• Share to Proton Pump Inhibitors
• Share to Asia